New Delhi: India could see a steep rise in cancer cases over the next two decades, with new diagnoses projected to increase from about 1.5 million annually to nearly 2.5 million by 2045, prompting health experts to warn that early detection and prevention must take centre stage alongside treatment expansion.
The warning was issued by Indian Cancer Society (ICS), Delhi, on the eve of World Cancer Day observed on Feb 4, during a media interaction held on Tuesday, as the Union Budget 2026–27 announced customs duty exemptions on select cancer drugs and a renewed push for domestic biopharma manufacturing to improve access to treatment.
While welcoming the Budget measures, public health experts cautioned that easing drug costs alone will not be enough to counter India’s growing cancer burden, especially when a large proportion of patients continue to reach hospitals at advanced stages of the disease.
Jyotsna Govil, Chairperson, ICS Delhi, said the focus must remain on preventing cancers where possible and detecting them early. “The Budget opens the door for more affordable treatment, but our effort is to ensure patients do not reach advanced stages where these medicines become their only option,” she said.
She underlined the organisation’s long-standing work on cancer prevention, patient support and advocacy. She highlighted the role of responsible media in dispelling myths, encouraging timely screening and ensuring evidence-based information reaches communities.
Presenting data on current trends, Dr Nitesh Rohatgi, senior director (Oncology) at Fortis Memorial Hospital, said age-appropriate screening, early diagnosis and newer diagnostic tools can significantly improve outcomes and reduce the overall cost of care.
Highlighting policy and systemic gaps, Dr Urvashi Prasad, cancer survivor and former director at NITI Aayog, said regional disparities, weak cancer data and financial barriers continue to delay diagnosis and treatment. She stressed the need for stronger Centre–state coordination and sustained public investment in cancer care.
Offering a survivor’s perspective, Renuka Prasad, secretary, ICS Delhi, spoke about the emotional, physical and financial toll of cancer on patients and families. She outlined the society’s community-focused initiatives, including large-scale screening programmes, the Prashanti healing and rehabilitation centre, digital outreach through the Rise Against Cancer app and patient support initiatives.
Addressing cancer prevention within the framework of universal health coverage, Dr Monika Puri, public health consultant and former official with the WHO, said prevention, screening and continuity of care must be integrated into primary health systems to ensure equitable access.
